Health ❯ Healthcare ❯ Drug Approval

Regulatory Affairs

Clinical Research European Medicines Agency Japan Ministry of Health Health Canada FDA Submissions FDA Approval Process Clinical Applications European Commission Global Regulatory Authorities FDA Oversight Wegovy

3 ARTICLES

9mo ago

Epcoritamab Improves PFS but Not OS in Phase 3 DLBCL Trial

The companies plan regulatory talks following a randomized study in transplant‑ineligible relapsed DLBCL that compared subcutaneous monotherapy against standard chemoimmunotherapy.

5 ARTICLES

last yr.

Moonlake Shares Plunge on Mixed Phase 3 Results for Hidradenitis Drug

3 ARTICLES

last yr.

European Commission Approves Voranigo for IDH-Mutant Grade 2 Glioma

3 ARTICLES

last yr.

Jaypirca Delivers Significant PFS Benefit Over Chemoimmunotherapy in First-Line CLL/SLL